Grifols (GRFS) Treasury Shares (2009 - 2025)
Grifols (GRFS) posted Treasury Shares of $152.5 million for Q4 2025, up 5.7% quarter-over-quarter from $144.3 million in Q4 2024, and up 5.7% year-on-year from $144.3 million in Q4 2024.
Grifols (GRFS) Treasury Shares (2009 - 2025) Analysis & Trends
Grifols (GRFS) has reported Treasury Shares for 15 consecutive years, with $152.5 million the latest figure, recorded in Q4 2025.
- Treasury Shares for Q4 2025 came in at $152.5 million, up 5.7% year-over-year; the trailing twelve-month figure through Dec 2025 was $152.5 million (up 5.7% YoY), and the FY2025 annual result was $152.5 million, up 5.7% from the prior year.
- Treasury Shares was $152.5 million for Q4 2025 at Grifols, up from $144.3 million in the prior quarter.
- Over five years, Treasury Shares peaked at $187.8 million in Q4 2021 and troughed at $144.3 million in Q4 2024.
- Average Treasury Shares over 5 years is $162.9 million, with a median of $164.3 million recorded in 2023.
- Year-over-year, Treasury Shares soared 260.21% in 2021 and dropped 12.22% in 2024.
- Over 5 years, Treasury Shares stood at $187.8 million in 2021, then slipped by 11.88% to $165.5 million in 2022, then dropped by 0.7% to $164.3 million in 2023, then retreated by 12.22% to $144.3 million in 2024, then climbed by 5.7% to $152.5 million in 2025.
- Per Business Quant data, the three most recent Treasury Shares figures were $152.5 million in Q4 2025, $144.3 million in Q4 2024, and $164.3 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 3.01 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 76.26 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 10.61 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 1.11 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 3.94 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -47.00 Mn |
| 10 | Grifols | - | - | - | 152.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 152.49 Mn |
| Dec 31, 2025 | 152.49 Mn |
| Dec 31, 2024 | 144.26 Mn |
| Dec 31, 2024 | 144.26 Mn |
| Dec 31, 2023 | 164.35 Mn |
| Dec 31, 2023 | 164.35 Mn |
| Dec 31, 2022 | 165.50 Mn |
| Dec 31, 2022 | 165.50 Mn |
| Dec 31, 2021 | 187.83 Mn |
| Dec 31, 2021 | 187.83 Mn |
| Dec 31, 2020 | 52.14 Mn |
| Dec 31, 2020 | 52.14 Mn |
| Sep 30, 2020 | -51.08 Mn |
| Sep 30, 2020 | -51.08 Mn |
| Mar 31, 2020 | -54.21 Mn |
| Mar 31, 2020 | -54.21 Mn |
| Dec 31, 2019 | 54.88 Mn |
| Dec 31, 2019 | 54.88 Mn |
| Sep 30, 2019 | -55.17 Mn |
| Sep 30, 2019 | -55.17 Mn |